REPROCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clini... cal testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.
REPROCELL
Industry:
Biotechnology Health Care Manufacturing Test And Measurement
Founded:
2003-01-01
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.reprocell.com
Total Employee:
51+
Status:
Active
Contact:
(814) 547-5388
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-04-25 | BioServe Biotechnologies (India) | BioServe Biotechnologies (India) acquired by ReproCELL | N/A |
| 2015-11-24 | Biopta | Biopta acquired by ReproCELL | N/A |
| 2014-08-05 | ReInnervate | ReInnervate acquired by ReproCELL | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-25 | Symic Biomedical | ReproCELL investment in Series C - Symic Biomedical | 11 M USD |
| 2016-12-05 | Kringle Pharma | ReproCELL investment in Venture Round - Kringle Pharma | 610 M JPY |
Official Site Inspections
http://www.reprocell.com Semrush global rank: 1.46 M Semrush visits lastest month: 18.72 K
- Host name: 109.108.148.102.srvlist.ukfast.net
- IP address: 109.108.148.102
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
